lutetium-177
Commercial- Indications
- Cancer, Prostate cancer, Kidney cancer, Neuroendocrine tumors
Company intelligence / Profile preview
Global Morpho Pharma
La Chapelle Sur Erdre, Pays de la Loire, Francemorphopharma.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Global Morpho Pharma is a French biotech company specializing in the development, manufacturing, and distribution of GMP-grade medical radioisotopes such as non-carrier added Lutetium‑177 (nca Lu‑177), Actinium‑225, and Terbium‑161. These isotopes are essential components in the rapidly growing field of nuclear medicine and targeted radiotherapeutics. The company focuses on improving accessibility and supply security for these critical materials to support pharmaceutical industry partners worldwide.
- Therapeutic areas
- Oncology
- Modalities
- RadiopharmaceuticalRadionuclide therapy (e.g., Lutetium-177, Actinium-225, Terbium-161)
- Industry
- Chemicals & Materials
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Not explicitly listed; the company positions itself as a partner to pharmaceutical companies developing radiotherapeutics.
Beyond the preview
Go deeper on Global Morpho Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Global Morpho Pharma.